Company Overview

Welpharm Co., Lts. Offer avermectin, abamectin, acarbose, etodolac, ivermectin, colistin sulphate, tilmicosin, flavomycin, toltrazuril, maduramicin ammonium, salinomycin, diclazuril, monensin, nicarbazin, dicamba, gibberellic acid, zaleplon.

Transactions
-

Business type	Manufacturer	Country / Region	Saitama, Japan
Main Products	Pharmaceuticals, Agrochemicals, Veterinary, Pesticides	Total employees	51 - 100 People
Total Annual Revenue	US$5 Million - US$10 Million	Year established	1988
Certifications	-	Product Certifications	-
Patents	-	Trademarks	-
Main Markets	Southeast Asia 50.00% Western Europe 50.00%

PRODUCT CAPACITY

Factory Information

Contract Manufacturing

Buyer Label Offered

TRADE CAPABILITIES

Main Markets & Product(s)

Main markets	Total Revenue(%)	Main Product(s)	Verified

Southeast Asia	50.00%
Western Europe	50.00%

Verified

Trade Ability

Total Annual Revenue

US$5 Million - US$10 Million